CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin regeneration, and novel solutions.
CarthroniX has raised $2.3M in total funding. The most recent round was Convertible Note. The last funding was announced in April 2022.
CarthroniX's investors include Pacira Pharmaceuticals.
CarthroniX is headquartered in Lancaster, United States.
CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin regeneration, and novel solutions.
CarthroniX is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CarthroniX — Funding & Investors." VCBacked, April 11, 2022, https://www.vcbacked.co/company/carthronix. Accessed September 30, 2026.
VCBacked. (2022). CarthroniX — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/carthronix
{{cite web |title=CarthroniX — Funding & Investors |url=https://www.vcbacked.co/company/carthronix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated